ALEXANDRIA, Va., June 9 -- United States Patent no. 12,285,393, issued on April 29, was assigned to Qun Lu (Greenville, N.C.).
"Roles of modulators of intersectin-Cdc42 signaling in Alzheimer's disease" was invented by Qun Lu (Greenville, N.C.), Yan-Hua Chen (Greenville, N.C.), Yi Zhu (Greenville, N.C.) and Byron Aguilar (Greenville, N.C.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Methods of treating Alzheimer's disease and other neurodegenerative and/or neurocognitive and/or neurodevelopmental diseases are described. The methods comprise the administration of compounds that modulate an activity of cell division control protein 42 (Cdc42), such as the interaction between Cdc42 and intersectin (ITSN). Exe...